Document is current
Any future updates will be listed below
-
Authors
Dou, Liping
Peng, Bo
Li, Xin
Wang, Lu
Jia, Mingyu
Xu, Lingmin
Li, Fei
Liu, Daihong https://orcid.org/0000-0001-7352-9560
-
Funding
Funding for this research was provided by:
military medical support innovation and generate special program (21WQ034)
- License Information
-
More Information
Article History
Received: 14 June 2021
Accepted: 25 May 2022
First Online: 6 June 2022
Declarations
:
: The study protocol has been approved by the leading independent Ethics Committee of the Chinese PLA General Hospital (S2019-177-01). The study will be conducted in accordance with the ethical principles of the Declaration of Helsinki. Patient’s written consent to participate in this clinical trial is obtained prior to any specific procedures, such as the use of blood samples and gut and skin biopsy. The study has been registered in the ClinicalTrials.gov registry (NCT04061876). The important protocol modifications (e.g., changes to eligibility criteria, outcomes, analyses) will be communicated to relevant parties (e.g., investigators, REC/IRBs, trial participants, trial registries, journals, regulators).
: The trial results can be communicated to participants, healthcare professionals, the public, and other relevant groups (e.g., via publication, reporting in results databases, or other data sharing arrangements).
: The authors declare that they have no competing interests.
